what we do
Raise Awareness on Patient Safety
Unsafe medicines undermine the health or patients and erode public confidence in healthcare systems. Strengthening safety begins with strengthening understanding — and trust.
Our work focuses on reducing the impact of unsafe medical products on patient well-being and strengthening the systems that safeguard medical product safety across the continent.
We raise awareness of medicines and patient safety challenges while promoting the shared responsibility of regulators, healthcare professionals, supply chain actors, manufacturers and communities to protect patients.
Through informed dialogue, regulatory engagement, independent analysis, and structured collaboration, we:
Trust is currency. It is the foundation for effective regulation and improved patient protection.
Unsafe medicines undermine the health or patients and erode public confidence in healthcare systems. Strengthening safety begins with strengthening understanding — and trust.
Our work focuses on reducing the impact of unsafe medical products on patient well-being and strengthening the systems that safeguard medical product safety across the continent.
We raise awareness of medicines and patient safety challenges while promoting the shared responsibility of regulators, healthcare professionals, supply chain actors, manufacturers and communities to protect patients.
Through informed dialogue, regulatory engagement, independent analysis, and structured collaboration, we:
- Elevate medicines and patient safety as a public health priority
- Encourage coordinated action among stakeholders
- Reduce risk through action-oriented initiatives
- Strengthen public trust in regulatory systems
- Deliver meaningful community-level impact
Trust is currency. It is the foundation for effective regulation and improved patient protection.
Strengthening Medicines Safety through Collaboration
Unsafe medical products are a multi-faceted challenge requiring coordinated, sustained action. Improving medicines safety demands engagement across regulators, healthcare professionals, patients, communities, manufacturers and others — working together to ensure oversight systems remain effective and responsive.
Our approach is constructive and system-focused. We:
By reinforcing cooperation across sectors, we contribute to stronger regulatory resilience and safer access to medicines.
Unsafe medical products are a multi-faceted challenge requiring coordinated, sustained action. Improving medicines safety demands engagement across regulators, healthcare professionals, patients, communities, manufacturers and others — working together to ensure oversight systems remain effective and responsive.
Our approach is constructive and system-focused. We:
- Engage stakeholders in collaborative efforts grounded in shared responsibility
- Support effective patient centric oversight mechanisms
- Reduce the prevalence of unsafe medical products
- Complement institutional progress across African markets
- Maintain a patient-centered, patient-centric focus in all our collaborations
By reinforcing cooperation across sectors, we contribute to stronger regulatory resilience and safer access to medicines.
|
Strategic Partnership for Safe Access Access to medicines must mean access to medicines that are safe and will not cause harm. Addressing medicines safety challenges requires coordination beyond individual institutions. Emerging risks must be examined collectively, and practical responses must be developed collaboratively. We facilitate structured engagement among regulatory authorities, health professionals, supply chain actors, and other key stakeholders to promote shared understanding — always with patient safety at the center. Through strategic partnerships and professional engagement, we:
|
|
Independent Insight
Clear understanding of medicines safety risks and regulatory developments is essential for effective oversight.
We provide analysis and perspective on issues affecting medicines safety, market integrity, and regulatory development across Africa.
Our contributions are guided by independence, professional integrity, and a commitment to advancing public interest in medicines safety and regulatory integrity.
